financetom
Business
financetom
/
Business
/
Siemens ties up with IISc, CMTI to set up digital transformation labs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Siemens ties up with IISc, CMTI to set up digital transformation labs
Feb 8, 2021 3:33 AM

Siemens on Monday said it has signed pacts with Indian Institute of Science (IISc) and Central Manufacturing Technology Institute (CMTI) to set up digital transformation labs. Siemens signed two separate memorandums of understanding (MoUs) with IISc and CMTI, respectively, to establish first-of-its-kind digital transformation labs, the company said in a statement.

The labs are aimed at enhancing the expertise of researchers at IISc as well as technical skills of professionals in the machine tool industry, it said, adding that the MoUs will focus on the development of industrial Internet of Things and Industry 4.0-enabled products and technologies.

This initiative will benefit many research scholars, students and industry professionals across the machine tool industry in Bengaluru for a period of three years, it noted. Special emphasis will be given to equip the labs with technologies, products and prototypes of emerging digital technologies such as digital twin, blockchain technology and automatic guided vehicle. This initiative will encourage adoption of smart digital technologies by MSMEs of manufacturing sector.

Sunil Mathur, MD and CEO of Siemens, said: With digital transformation now a priority for industry, premier educational institutions such as IISc and CMTI have a crucial role to play in equipping researchers and professionals with cutting-edge technology and expertise.

The Smart Factory at IISc and the Smart Manufacturing Demo and Development Cell at CMTI are two of the five experiential and demonstration centers for Industry 4.0 sanctioned under the Smart Advanced Manufacturing and Rapid Transformation Hub (SAMARTH) Udyog initiative of the Ministry of Heavy Industries and Public Enterprises, Government of India.

The support from Siemens will be used to develop IIoT/Industry 4.0 enabled digital twin-based platform for machine tool industry and a machine tool health monitoring app on the platform, the statement added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Correction: EnVVeno Medical Prices $15 Million Public Offering
Correction: EnVVeno Medical Prices $15 Million Public Offering
Sep 29, 2024
01:03 PM EDT, 09/27/2024 (MT Newswires) -- (Corrects the company name in the headline.) EnVVeno Medical ( NVNO ) said Thursday it has priced a public offering of about 4.3 million common shares or pre-funded warrants at $3.50 per share for expected gross proceeds of about $15 million. The underwriter has been granted a 30-day option to purchase up to...
Update: Defense Metals Signs MOU with Sask. Research Council to Enhance Rare Earth Element Supply Chain
Update: Defense Metals Signs MOU with Sask. Research Council to Enhance Rare Earth Element Supply Chain
Sep 29, 2024
12:01 PM EDT, 09/27/2024 (MT Newswires) -- Defense Metals ( DFMTF ) late on Thursday said it signed a memorandum of understanding with the Saskatchewan Research Council (SRC) to help strengthen the rare earth element supply chain in Canada. The MOU outlines a framework for Defense Metals ( DFMTF ) and SRC to leverage their capabilities in the supply and...
Ryde Closes $4.5 Million Public Offering
Ryde Closes $4.5 Million Public Offering
Sep 29, 2024
12:38 PM EDT, 09/27/2024 (MT Newswires) -- Ryde Group ( RYDE ) on Friday announced the closing of a $4.5 million public offering. The company issued 5.3 million units at $0.85 each. Each unit is made up of a Class A common share and a warrant that can be exchanged for a common stock at $0.85 apiece. Shares of the...
Cytokinetics New Analysis of Heart Medication Study Shows Beneficial Changes
Cytokinetics New Analysis of Heart Medication Study Shows Beneficial Changes
Sep 29, 2024
12:40 PM EDT, 09/27/2024 (MT Newswires) -- Cytokinetics ( CYTK ) said Friday that findings from a new analysis of phase 3 trial of aficamten, its investigational drug for treating heart muscle thickening, showed beneficial changes. Cytokinetics ( CYTK ) said the analysis showed about 84% of patients treated with aficamten experienced favorable effects in at least one of the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved